• In recent days, e.l.f. Beauty reported FY26 net sales growth of 25%, powered by rapid international rollout and the high-growth Rhode skincare brand, even as higher costs and tariffs led to a GAAP loss.
• What stands out is how e.l.f. is using Rhode’s global expansion and one-time tariff refunds to reposition the portfolio and support future unit growth despite margin pressure and sector skepticism.
• We’ll now examine how Rhode’s accelerating international expansion reshapes e.l.f. Beauty’s existing investment narrative for growth, risk, and diversification.

Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

e.l.f. Beauty Investment Narrative Recap

To own e.l.f. Beauty today, you have to believe that its combination of value pricing, digital marketing and now the Rhode franchise can keep driving healthy top line growth even as tariffs and higher costs weigh on profits. The latest results reinforce the near term catalyst around Rhode’s international rollout and the planned reinvestment of one time tariff refunds into unit growth, while also underlining that tariff driven margin pressure remains the most immediate risk.

Against that backdrop, Bernstein’s recent Market Perform initiation with a US$60 target and focus on earnings volatility after the Rhode acquisition feels especially relevant. Their call highlights how increased marketing and payroll tied to the enlarged portfolio, along with choppy margins, are front of mind for more cautious analysts at a time when management is leaning into Rhode expansion and international growth as key drivers of the next leg of the story.

Yet investors should also be aware that, despite e.l.f.’s strong growth narrative, its heavy reliance on a China based supply chain and potential tariff costs of roughly US$50 million a year could...

e.l.f. Beauty's narrative projects $2.1 billion revenue and $156.2 million earnings by 2029. This requires 9.2% yearly revenue growth and about a $129.9 million earnings increase from $26.3 million today.

Uncover how e.l.f. Beauty's forecasts yield a $72.40 fair value, a 18% upside to its current price.

Exploring Other Perspectives

More optimistic analysts were assuming revenue could reach about US$2.1 billion and earnings US$183 million by 2029, but this latest Rhode led surge and tariff hit may either reinforce that bullish view or push expectations closer to the more cautious read on China supply and digital marketing risks, which is why you should look at several competing narratives before deciding what you believe.

Explore 10 other fair value estimates on e.l.f. Beauty - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your e.l.f. Beauty research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.
• Our free e.l.f. Beauty research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate e.l.f. Beauty's overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 31 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.